{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:04:24Z","timestamp":1786763064484,"version":"build-2736575974"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00818-1","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:37:24Z","timestamp":1782459444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Convergent blood\u2013brain barrier breakdown in schizophrenia and autism spectrum disorders: a systematic review of preclinical animal models"],"prefix":"10.1186","volume":"23","author":[{"given":"Cristina","family":"Morente-Montilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"G\u00f3mez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Garc\u00eda-Cerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Moreno-Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermona","family":"Soreq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Deli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Mart\u00edn-Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio S.","family":"Riga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"1","key":"818_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41398-024-02866-3","volume":"14","author":"VR Bourque","year":"2024","unstructured":"Bourque VR, Poulain C, Proulx C, Moreau CA, Joober R, Forgeot d\u2019Arc B, et al. Genetic and phenotypic similarity across major psychiatric disorders: a systematic review and quantitative assessment. Transl Psychiatry. 2024, Mar, 30;14(1):171. https:\/\/doi.org\/10.1038\/s41398-024-02866-3.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"818_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41582-023-00896-x","volume":"20","author":"KJ Peall","year":"2024","unstructured":"Peall KJ, Owen MJ, Hall J. Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes. Nat Rev Neurol. 2024, Jan;20(1):7\u201321. https:\/\/doi.org\/10.1038\/s41582-023-00896-x.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"818_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamapsychiatry.2020.3908","volume":"78","author":"LD Oliver","year":"2021","unstructured":"Oliver LD, Moxon-Emre I, Lai MC, Grennan L, Voineskos AN, Ameis SH. Social cognitive performance in schizophrenia spectrum disorders compared with autism spectrum disorder: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry. 2021, Mar, 1;78(3):281\u201392. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3908 PubMed PMID: 33291141; PubMed Central PMCID: PMC7724568.","journal-title":"JAMA Psychiatry"},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"105441","DOI":"10.1016\/j.neubiorev.2023.105441","volume":"155","author":"SU Ozbek","year":"2023","unstructured":"Ozbek SU, Sut E, Bora E. Comparison of social cognition and neurocognition in schizophrenia and autism spectrum disorder: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2023, Dec;155:105441. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105441.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"2","key":"818_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/mp.2016.198","volume":"23","author":"B St Pourcain","year":"2018","unstructured":"St Pourcain B, Robinson EB, Anttila V, Sullivan BB, Maller J, Golding J, et al. ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol. Psychiatry. 2018, Feb;23(2):263\u201370. https:\/\/doi.org\/10.1038\/mp.2016.198 PubMed PMID: 28044064; PubMed Central PMCID: PMC5382976.","journal-title":"Mol. Psychiatry"},{"key":"818_CR6","doi-asserted-by":"publisher","first-page":"104543","DOI":"10.1016\/j.neubiorev.2022.104543","volume":"134","author":"KJ Varcin","year":"2022","unstructured":"Varcin KJ, Herniman SE, Lin A, Chen Y, Perry Y, Pugh C, et al. Occurrence of psychosis and bipolar disorder in adults with autism: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2022, Mar;134:104543. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104543.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"104577","DOI":"10.1016\/j.neubiorev.2022.104577","volume":"135","author":"S Santos","year":"2022","unstructured":"Santos S, Ferreira H, Martins J, Gon\u00e7alves J, Castelo-Branco M. Male sex bias in early and late onset neurodevelopmental disorders: shared aspects and differences in autism spectrum disorder, attention Deficit\/hyperactivity disorder, and schizophrenia. Neurosci. Biobehav. Rev. 2022, Apr;135:104577. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104577 PubMed PMID: 35167846.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"1","key":"818_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13229-020-00370-1","volume":"11","author":"C Cheroni","year":"2020","unstructured":"Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020, Dec;11(1):69. https:\/\/doi.org\/10.1186\/s13229-020-00370-1.","journal-title":"Mol Autism"},{"issue":"1","key":"818_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","volume":"8","author":"A Modabbernia","year":"2017","unstructured":"Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol Autism. 2017, Dec;8(1):13. https:\/\/doi.org\/10.1186\/s13229-017-0121-4.","journal-title":"Mol Autism"},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"104894","DOI":"10.1016\/j.neubiorev.2022.104894","volume":"142","author":"MJ Rantala","year":"2022","unstructured":"Rantala MJ, Luoto S, Borr\u00e1z-Le\u00f3n JI, Krams I. Schizophrenia: the new etiological synthesis. Neurosci. Biobehav. Rev. 2022, Nov;142:104894. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104894.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"3","key":"818_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2020.03.008","volume":"89","author":"J Richetto","year":"2021","unstructured":"Richetto J, Meyer U. Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability. Biol Psychiatry. 2021, Feb;89(3):215\u201326. https:\/\/doi.org\/10.1016\/j.biopsych.2020.03.008.","journal-title":"Biol Psychiatry"},{"key":"818_CR12","doi-asserted-by":"publisher","unstructured":"GBD, 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global burden of disease study 2019. Lancet Psychiatry. 2022, Feb;9(2):137\u201350. https:\/\/doi.org\/10.1016\/S2215-0366(21)00395-3 PubMed PMID: 35026139; PubMed Central PMCID: PMC8776563.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"issue":"1","key":"818_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol. Psychiatry. 2022, Jan;27(1):281\u201395. https:\/\/doi.org\/10.1038\/s41380-021-01161-7 PubMed PMID: 34079068; PubMed Central PMCID: PMC8960395.","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"818_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/aur.2696","volume":"15","author":"J Zeidan","year":"2022","unstructured":"Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: a systematic review update. Autism Res. 2022, May;15(5):778\u201390. https:\/\/doi.org\/10.1002\/aur.2696 PubMed PMID: 35238171; PubMed Central PMCID: PMC9310578.","journal-title":"Autism Res"},{"issue":"11","key":"818_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41583-021-00507-y","volume":"22","author":"TE Faust","year":"2021","unstructured":"Faust TE, Gunner G, Schafer DP. Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS. Nat. Rev. Neurosci. 2021, Nov;22(11):657\u201373. https:\/\/doi.org\/10.1038\/s41583-021-00507-y.","journal-title":"Nat. Rev. Neurosci"},{"issue":"1","key":"818_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41380-021-01092-3","volume":"27","author":"Z Yan","year":"2022","unstructured":"Yan Z, Rein B. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications. Mol. Psychiatry. 2022, Jan;27(1):445\u201365. https:\/\/doi.org\/10.1038\/s41380-021-01092-3.","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"818_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41593-023-01404-6","volume":"26","author":"A Segal","year":"2023","unstructured":"Segal A, Parkes L, Aquino K, Kia SM, Wolfers T, Franke B, et al. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. Nat. Neurosci. 2023, Sep;26(9):1613\u201329. https:\/\/doi.org\/10.1038\/s41593-023-01404-6.","journal-title":"Nat. Neurosci"},{"key":"818_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neubiorev.2018.02.010","volume":"97","author":"BE Hornix","year":"2019","unstructured":"Hornix BE, Havekes R, Kas MJH. Multisensory cortical processing and dysfunction across the neuropsychiatric spectrum. Neurosci. Biobehav. Rev. 2019, Feb;97:138\u201351. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.02.010.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"7","key":"818_CR19","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/brain\/awab096","volume":"144","author":"CA Moreau","year":"2021","unstructured":"Moreau CA, Raznahan A, Bellec P, Chakravarty M, Thompson PM, Jacquemont S. Dissecting autism and schizophrenia through neuroimaging genomics. Brain. 2021, Aug, 17;144(7):1943\u201357. https:\/\/doi.org\/10.1093\/brain\/awab096.","journal-title":"Brain"},{"issue":"6","key":"818_CR20","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/schbul\/sbae044","volume":"50","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li W, Lv L, Yue W. Shared genetic determinants of schizophrenia and autism spectrum disorder implicate opposite risk patterns: a genome-wide analysis of common variants. Schizophr Bull. 2024, Nov, 8;50(6):1382\u201395. https:\/\/doi.org\/10.1093\/schbul\/sbae044.","journal-title":"Schizophr Bull"},{"issue":"1","key":"818_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s42003-021-02592-2","volume":"4","author":"Y Du","year":"2021","unstructured":"Du Y, Fu Z, Xing Y, Lin D, Pearlson G, Kochunov P, et al. Evidence of shared and distinct functional and structural brain signatures in schizophrenia and autism spectrum disorder. Commun Biol. 2021, Sep, 14;4(1):1073. https:\/\/doi.org\/10.1038\/s42003-021-02592-2.","journal-title":"Commun Biol"},{"issue":"7","key":"818_CR22","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/brain\/awaf068","volume":"148","author":"R Rust","year":"2025","unstructured":"Rust R, Yin H, Ach\u00f3n Buil B, Sagare AP, Kisler K. The blood\u2013brain barrier: a help and a hindrance. Brain. 2025, Jul, 7;148(7):2262\u201382. https:\/\/doi.org\/10.1093\/brain\/awaf068.","journal-title":"Brain"},{"issue":"14","key":"818_CR23","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/cells11142211","volume":"11","author":"R Jagadapillai","year":"2022","unstructured":"Jagadapillai R, Qiu X, Ojha K, Li Z, El-Baz A, Zou S, et al. Potential cross talk between autism risk genes and neurovascular molecules: a pilot study on impact of blood brain barrier integrity. Cells. 2022, Jul, 15;11(14):2211. https:\/\/doi.org\/10.3390\/cells11142211 PubMed PMID: 35883654; PubMed Central PMCID: PMC9315816.","journal-title":"Cells"},{"issue":"726","key":"818_CR24","doi-asserted-by":"publisher","first-page":"133664","DOI":"10.1016\/j.neulet.2018.06.033","volume":"726","author":"J Kealy","year":"2020","unstructured":"Kealy J, Greene C, Campbell M. Blood-brain barrier regulation in psychiatric disorders. Neurosci Lett. 2020, May;726(726):133664. https:\/\/doi.org\/10.1016\/j.neulet.2018.06.033 PubMed PMID: 29966749.","journal-title":"Neurosci Lett"},{"key":"818_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbi.2024.11.006","volume":"123","author":"Z Maridaki","year":"2025","unstructured":"Maridaki Z, Syrros G, Gianna Delichatsiou S, Warsh J, Konstantinou GN. Claudin-5 and occludin levels in patients with psychiatric disorders \u2212 a systematic review. Brain Behav Immun. 2025, Jan;123:865\u201375. https:\/\/doi.org\/10.1016\/j.bbi.2024.11.006 PubMed PMID: 39500414.","journal-title":"Brain Behav Immun"},{"issue":"128","key":"818_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbi.2025.04.003","volume":"128","author":"J Moussiopoulou","year":"2025","unstructured":"Moussiopoulou J, Yakimov V, Roell L, Rauchmann BS, Toth H, Melcher J, et al. Higher blood\u2013brain barrier leakage in schizophrenia-spectrum disorders: a comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls. Brain Behav Immun. 2025, Apr;128(128):256\u201365. https:\/\/doi.org\/10.1016\/j.bbi.2025.04.003 PubMed PMID: 40194748.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"818_CR27","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1038\/s41380-023-02255-0","volume":"28","author":"P Lizano","year":"2023","unstructured":"Lizano P, Pong S, Santarriaga S, Bannai D, Karmacharya R. Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders. Mol. Psychiatry. 2023, Sep;28(9):3698\u2013708. https:\/\/doi.org\/10.1038\/s41380-023-02255-0 PubMed PMID: 37730841.","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"818_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41398-020-01054-3","volume":"10","author":"C Greene","year":"2020","unstructured":"Greene C, Hanley N, Campbell M. Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Transl Psychiatry. 2020, Nov, 2;10(1):373. https:\/\/doi.org\/10.1038\/s41398-020-01054-3 PubMed PMID: 33139732; PubMed Central PMCID: PMC7606459.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"818_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/18756190MTA44NjEs3","volume":"19","author":"U Langeh","year":"2021","unstructured":"Langeh U. Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders. CN. 2021;19(2):265\u201377. https:\/\/doi.org\/10.2174\/18756190MTA44NjEs3 PubMed PMID: 32727332; PubMed Central PMCID: PMC8033985.","journal-title":"CN"},{"issue":"2","key":"818_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.14574","volume":"148","author":"F Michetti","year":"2019","unstructured":"Michetti F, D\u2019Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, et al. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019, Jan;148(2):168\u201387. https:\/\/doi.org\/10.1111\/jnc.14574 PubMed PMID: 30144068.","journal-title":"J Neurochem"},{"issue":"8","key":"818_CR31","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s10803-020-04710-1","volume":"51","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zheng P, Zou X. Peripheral blood S100B levels in autism spectrum disorder: a systematic review and meta-analysis. J Autism Dev Disord. 2021, Aug;51(8):2569\u201377. https:\/\/doi.org\/10.1007\/s10803-020-04710-1 PubMed PMID: 33006697; PubMed Central PMCID: PMC8254719.","journal-title":"J Autism Dev Disord"},{"key":"818_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.bbi.2024.04.011","volume":"119","author":"M Campana","year":"2024","unstructured":"Campana M, Yakimov V, Moussiopoulou J, Maurus I, L\u00f6hrs L, Raabe F, et al. Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders \u2013 an individual patient data meta-analysis. Brain Behav Immun. 2024, Jul;119:353\u201362. https:\/\/doi.org\/10.1016\/j.bbi.2024.04.011 PubMed PMID: 38608742.","journal-title":"Brain Behav Immun"},{"key":"818_CR33","doi-asserted-by":"publisher","first-page":"100989","DOI":"10.1016\/j.yfrne.2022.100989","volume":"65","author":"L Dion-Albert","year":"2022","unstructured":"Dion-Albert L, Bandeira Binder L, Daigle B, Hong-Minh A, Lebel M, Menard C. Sex differences in the blood\u2013brain barrier: implications for mental health. Front Neuroendocrinol. 2022, Apr;65:100989. https:\/\/doi.org\/10.1016\/j.yfrne.2022.100989 PubMed PMID: 35271863.","journal-title":"Front Neuroendocrinol"},{"issue":"23","key":"818_CR34","doi-asserted-by":"publisher","first-page":"15271","DOI":"10.3390\/ijms232315271","volume":"23","author":"A Arag\u00f3n-Gonz\u00e1lez","year":"2022","unstructured":"Arag\u00f3n-Gonz\u00e1lez A, Shaw PJ, Ferraiuolo L. Blood\u2013brain barrier disruption and its involvement in neurodevelopmental and neurodegenerative disorders. IJMS. 2022, Dec, 3;23(23):15271. https:\/\/doi.org\/10.3390\/ijms232315271 PubMed PMID: 36499600; PubMed Central PMCID: PMC9737531.","journal-title":"IJMS"},{"issue":"7","key":"818_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tins.2023.04.007","volume":"46","author":"EE Crouch","year":"2023","unstructured":"Crouch EE, Joseph T, Marsan E, Huang EJ. Disentangling brain vasculature in neurogenesis and neurodegeneration using single-cell transcriptomics. Trends Neurosciences. 2023, Jul;46(7):551\u201365. https:\/\/doi.org\/10.1016\/j.tins.2023.04.007 PubMed PMID: 37210315; PubMed Central PMCID: PMC10560453.","journal-title":"Trends Neurosciences"},{"issue":"12","key":"818_CR36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/nm1296-1382","volume":"2","author":"A Friedman","year":"1996","unstructured":"Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med. 1996, Dec;2(12):1382\u201385. https:\/\/doi.org\/10.1038\/nm1296-1382 PubMed PMID: 8946841.","journal-title":"Nat Med"},{"issue":"1","key":"818_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","volume":"16","author":"C Greene","year":"2019","unstructured":"Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS. 2019, Jan, 29;16(1):3. https:\/\/doi.org\/10.1186\/s12987-019-0123-z PubMed PMID: 30691500; PubMed Central PMCID: PMC6350359.","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"818_CR38","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/mp.2017.156","volume":"23","author":"C Greene","year":"2018","unstructured":"Greene C, Kealy J, Humphries MM, Gong Y, Hou J, Hudson N, et al. Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Mol. Psychiatry. 2018, Nov;23(11):2156\u201366. https:\/\/doi.org\/10.1038\/mp.2017.156 PubMed PMID: 28993710; PubMed Central PMCID: PMC6298981.","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"818_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/WNF.0000000000000590","volume":"47","author":"Aydogan Av\u015far","year":"2024","unstructured":"Aydogan Av\u015far, Akku\u015f M, Aydogan Av\u015far P. ZO-1 serum levels as a potential biomarker for psychotic disorder. Clin Neuropharmacol. 2024, Jun, 1;47(3):67\u201371. https:\/\/doi.org\/10.1097\/WNF.0000000000000590 PubMed PMID: 38743599.","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"818_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00406-020-01152-9","volume":"271","author":"A Usta","year":"2021","unstructured":"Usta A, K\u0131l\u0131\u00e7 F, Demirda\u015f A, I\u015f\u0131k \u00dc, Do\u011fu\u00e7 DK, Bozkurt M. Serum zonulin and claudin-5 levels in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2021, Jun;271(4):767\u201373. https:\/\/doi.org\/10.1007\/s00406-020-01152-9 PubMed PMID: 32564127.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10202","key":"818_CR41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019, Sep, 14;394(10202):939\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(19)31135-3 PubMed PMID: 31303314; PubMed Central PMCID: PMC6891890.","journal-title":"Lancet"},{"issue":"1","key":"818_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020, Jan;7(1):64\u201377. https:\/\/doi.org\/10.1016\/S2215-0366(19)30416-X.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"818_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1192\/bjp.2021.61","volume":"220","author":"D Siskind","year":"2022","unstructured":"Siskind D, Orr S, Sinha S, Yu O, Brijball B, Warren N, et al. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. Br J Psychiatry. 2022, Mar;220(3):115\u201320. https:\/\/doi.org\/10.1192\/bjp.2021.61.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"818_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13229-024-00585-6","volume":"15","author":"H Choi","year":"2024","unstructured":"Choi H, Kim JH, Yang HS, Kim JY, Cortese S, Smith L, et al. Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment. Mol Autism. 2024, Jan, 23;15(1):7. https:\/\/doi.org\/10.1186\/s13229-024-00585-6 PubMed PMID: 38263251; PubMed Central PMCID: PMC10807060.","journal-title":"Mol Autism"},{"issue":"2","key":"818_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/wps.20881","volume":"20","author":"CU Correll","year":"2021","unstructured":"Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, et al. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry. 2021, Jun;20(2):244\u201375. https:\/\/doi.org\/10.1002\/wps.20881.","journal-title":"World Psychiatry"},{"issue":"2","key":"818_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jaac.2022.03.033","volume":"62","author":"G Salazar de Pablo","year":"2023","unstructured":"Salazar de Pablo G, Pastor Jord\u00e1 C, Vaquerizo-Serrano J, Moreno C, Cabras A, Arango C, et al. Systematic review and meta-analysis: efficacy of pharmacological interventions for irritability and emotional dysregulation in autism spectrum disorder and predictors of response. J Am Acad Child Psy. 2023, Feb;62(2):151\u201368. https:\/\/doi.org\/10.1016\/j.jaac.2022.03.033 PubMed PMID: 35470032.","journal-title":"J Am Acad Child Psy"},{"issue":"1","key":"818_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12888-020-2477-9","volume":"20","author":"Y Yu","year":"2020","unstructured":"Yu Y, Chaulagain A, Pedersen SA, Lydersen S, Leventhal BL, Szatmari P, et al. Pharmacotherapy of restricted\/repetitive behavior in autism spectrum disorder: a systematic review and meta-analysis. BMC Psychiatry. 2020, Mar, 12;20(1):121. https:\/\/doi.org\/10.1186\/s12888-020-2477-9 PubMed PMID: 32164636; PubMed Central PMCID: PMC7068977.","journal-title":"BMC Psychiatry"},{"key":"818_CR48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.neubiorev.2020.04.012","volume":"113","author":"FL Haddad","year":"2020","unstructured":"Haddad FL, Patel SV, Schmid S. Maternal immune activation by Poly I: C as a preclinical model for neurodevelopmental disorders: a focus on autism and schizophrenia. Neurosci. Biobehav. Rev. 2020, Jun;113:546\u201367. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.04.012.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.semcdb.2019.06.001","volume":"94","author":"M Bordeleau","year":"2019","unstructured":"Bordeleau M, Carrier M, Luheshi GN, Tremblay M\u00c8. Microglia along sex lines: from brain colonization, maturation and function, to implication in neurodevelopmental disorders. Semin Cell Dev Biol. 2019, Oct;94:152\u201363. https:\/\/doi.org\/10.1016\/j.semcdb.2019.06.001 PubMed PMID: 31201858.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"818_CR50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12974-017-0938-y","volume":"14","author":"J Prata","year":"2017","unstructured":"Prata J, Santos SG, Almeida MI, Coelho R, Barbosa MA. Bridging autism spectrum disorders and schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations. J Neuroinflammation. 2017, Sep, 4;14(1):179. https:\/\/doi.org\/10.1186\/s12974-017-0938-y PubMed PMID: 28870209; PubMed Central PMCID: PMC5584030.","journal-title":"J Neuroinflammation"},{"issue":"22","key":"818_CR51","doi-asserted-by":"publisher","first-page":"12366","DOI":"10.3390\/ijms252212366","volume":"25","author":"R Tumdam","year":"2024","unstructured":"Tumdam R, Hussein Y, Garin-Shkolnik T, Stern S. NMDA receptors in neurodevelopmental disorders: pathophysiology and disease models. IJMS. 2024, Nov, 18;25(22):12366. https:\/\/doi.org\/10.3390\/ijms252212366 PubMed PMID: 39596430; PubMed Central PMCID: PMC11594297.","journal-title":"IJMS"},{"key":"818_CR52","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.neubiorev.2016.04.008","volume":"68","author":"T Copf","year":"2016","unstructured":"Copf T. Impairments in dendrite morphogenesis as etiology for neurodevelopmental disorders and implications for therapeutic treatments. Neurosci. Biobehav. Rev. 2016, Sep;68:946\u201378. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.04.008 PubMed PMID: 27143622.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.conb.2019.01.004","volume":"57","author":"G Lima Caldeira","year":"2019","unstructured":"Lima Caldeira G, Pe\u00e7a, Carvalho AL, Pe\u00e7a J. New insights on synaptic dysfunction in neuropsychiatric disorders. Curr Opin Neurobiol. 2019, Aug;57:62\u201370. https:\/\/doi.org\/10.1016\/j.conb.2019.01.004 PubMed PMID: 30743178.","journal-title":"Curr Opin Neurobiol"},{"issue":"129","key":"818_CR54","doi-asserted-by":"publisher","first-page":"110876","DOI":"10.1016\/j.pnpbp.2023.110876","volume":"129","author":"S Reyes-Lizaola","year":"2024","unstructured":"Reyes-Lizaola S, Luna-Zarate U, Tendilla-Beltr\u00e1n H, Morales-Medina JC, Flores G. Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses. Prog Neuropsychopharmacol Biol Psychiatry. 2024, Feb;129(129):110876. https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110876 PubMed PMID: 37863171.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"818_CR55","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.pnpbp.2017.12.001","volume":"84","author":"J Luo","year":"2018","unstructured":"Luo J, Norris RH, Gordon SL, Nithianantharajah J. Neurodevelopmental synaptopathies: insights from behaviour in rodent models of synapse gene mutations. Prog Neuropsychopharmacol Biol Psychiatry. 2018, Jun;84;84(Pt B): 424\u201339. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.12.001 PubMed PMID: 29217145.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"818_CR56","doi-asserted-by":"publisher","first-page":"105488","DOI":"10.1016\/j.neubiorev.2023.105488","volume":"156","author":"B Gillespie","year":"2024","unstructured":"Gillespie B, Panthi S, Sundram S, Hill RA. The impact of maternal immune activation on GABAergic interneuron development: a systematic review of rodent studies and their translational implications. Neurosci. Biobehav. Rev. 2024, Jan;156:105488. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105488.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"2","key":"818_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrn3155","volume":"13","author":"O Mar\u00edn","year":"2012","unstructured":"Mar\u00edn O. Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci. 2012, Jan, 18;13(2):107\u201320. https:\/\/doi.org\/10.1038\/nrn3155 PubMed PMID: 22251963.","journal-title":"Nat. Rev. Neurosci"},{"issue":"2","key":"818_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41386-020-0778-9","volume":"46","author":"JB Ruden","year":"2021","unstructured":"Ruden JB, Dugan LL, Konradi C. Parvalbumin interneuron vulnerability and brain disorders. Neuropsychopharmacol. 2021, Jan;46(2):279\u201387. https:\/\/doi.org\/10.1038\/s41386-020-0778-9.","journal-title":"Neuropsychopharmacol"},{"key":"818_CR59","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.conb.2017.12.013","volume":"48","author":"I Del Pino","year":"2018","unstructured":"Del Pino I, Rico B, Mar\u00edn, Mar\u00edn O. Neural circuit dysfunction in mouse models of neurodevelopmental disorders. Curr Opin Neurobiol. 2018, Feb;48:174\u201382. https:\/\/doi.org\/10.1016\/j.conb.2017.12.013 PubMed PMID: 29329089.","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"818_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-genet-072820-023642","volume":"56","author":"D Exposito-Alonso","year":"2022","unstructured":"Exposito-Alonso D, Rico B. Mechanisms underlying circuit dysfunction in neurodevelopmental disorders. Annu Rev Genet. 2022, Nov;56(1):391\u2013422. https:\/\/doi.org\/10.1146\/annurev-genet-072820-023642 PubMed PMID: 36055969.","journal-title":"Annu Rev Genet"},{"issue":"1","key":"818_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jnc.15460","volume":"159","author":"E Gozal","year":"2021","unstructured":"Gozal E, Jagadapillai R, Cai J, Barnes GN. Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: implications for blood\u2013brain barrier integrity in autism spectrum disorder. J Neurochem. 2021, Oct;159(1):15\u201328. https:\/\/doi.org\/10.1111\/jnc.15460 PubMed PMID: 34169527; PubMed Central PMCID: PMC8484047.","journal-title":"J Neurochem"},{"key":"818_CR62","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neubiorev.2017.04.003","volume":"77","author":"P Katsel","year":"2017","unstructured":"Katsel P, Roussos P, Pletnikov M, Haroutunian V. Microvascular anomaly conditions in psychiatric disease. Schizophrenia \u2013 angiogenesis connection. Neurosci. Biobehav. Rev. 2017, Jun;77:327\u201339. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.04.003 PubMed PMID: 28396239; PubMed Central PMCID: PMC5497758.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR63","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, Jul, 21;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097 PubMed PMID: 19621072; PubMed Central PMCID: PMC2707599.","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"1","key":"818_CR64","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016, Dec, 5;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4 PubMed PMID: 27919275; PubMed Central PMCID: PMC5139140.","journal-title":"Syst Rev"},{"issue":"1","key":"818_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014, Mar;14(1):43. https:\/\/doi.org\/10.1186\/1471-2288-14-43 PubMed PMID: 24667063; PubMed Central PMCID: PMC4230647.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"818_CR66","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1242\/jcs.113.11.1851","volume":"113","author":"M Sheng","year":"2000","unstructured":"Sheng M, Kim E. The shank family of scaffold proteins. J Cell Sci. 2000, Jun;113(11):1851\u201356. https:\/\/doi.org\/10.1242\/jcs.113.11.1851 PubMed PMID: 10806096.","journal-title":"J Cell Sci"},{"issue":"6","key":"818_CR67","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/522590","volume":"81","author":"R Moessner","year":"2007","unstructured":"Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 2007, Dec;81(6):1289\u201397. https:\/\/doi.org\/10.1086\/522590 PubMed PMID: 17999366; PubMed Central PMCID: PMC2276348.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"818_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s11689-021-09397-8","volume":"13","author":"JP Delling","year":"2021","unstructured":"Delling JP, Boeckers TM. Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications. J Neurodevelop Disord. 2021, Nov, 16;13(1):55. https:\/\/doi.org\/10.1186\/s11689-021-09397-8 PubMed PMID: 34784886; PubMed Central PMCID: PMC8594088.","journal-title":"J Neurodevelop Disord"},{"issue":"7344","key":"818_CR69","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature09965","volume":"472","author":"J Pe\u00e7a","year":"2011","unstructured":"Pe\u00e7a J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011, Apr, 28;472(7344):437\u201342. https:\/\/doi.org\/10.1038\/nature09965 PubMed PMID: 21423165; PubMed Central PMCID: PMC3090611.","journal-title":"Nature"},{"issue":"15","key":"818_CR70","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/hmg\/ddr212","volume":"20","author":"X Wang","year":"2011","unstructured":"Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet. 2011, Aug, 1;20(15):3093\u2013108. https:\/\/doi.org\/10.1093\/hmg\/ddr212 PubMed PMID: 21558424; PubMed Central PMCID: PMC3131048.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"818_CR71","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41467-025-56720-1","volume":"16","author":"YE Kim","year":"2025","unstructured":"Kim YE, Kim M, Kim S, Lee R, Ujihara Y, Marquez-Wilkins EM, et al. Endothelial SHANK3 regulates tight junctions in the neonatal mouse blood-brain barrier through \u03b2-catenin signaling. Nat Commun. 2025, Feb, 6;16(1):1407. https:\/\/doi.org\/10.1038\/s41467-025-56720-1 PubMed PMID: 39915488; PubMed Central PMCID: PMC11802743.","journal-title":"Nat Commun"},{"key":"818_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcdb.2014.11.004","volume":"38","author":"RF Haseloff","year":"2015","unstructured":"Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE. Transmembrane proteins of the tight junctions at the blood\u2013brain barrier: structural and functional aspects. Semin Cell Dev Biol. 2015, Feb;38:16\u201325. https:\/\/doi.org\/10.1016\/j.semcdb.2014.11.004 PubMed PMID: 25433243.","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"818_CR73","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cell.2006.06.043","volume":"126","author":"K Umeda","year":"2006","unstructured":"Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell. 2006, Aug, 25;126(4):741\u201354. https:\/\/doi.org\/10.1016\/j.cell.2006.06.043 PubMed PMID: 16923393.","journal-title":"Cell"},{"issue":"9","key":"818_CR74","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrm.2016.80","volume":"17","author":"C Zihni","year":"2016","unstructured":"Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016, Sep;17(9):564\u201380. https:\/\/doi.org\/10.1038\/nrm.2016.80 PubMed PMID: 27353478.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"818_CR75","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1523\/JNEUROSCI.23-17-06671.2003","volume":"23","author":"A Sahay","year":"2003","unstructured":"Sahay A, Molliver ME, Ginty DD, Kolodkin AL. Semaphorin 3F is critical for development of limbic system circuitry and is required in neurons for selective CNS axon guidance events. J Neurosci. 2003, Jul, 30;23(17):6671\u201380. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-17-06671.2003 PubMed PMID: 12890759; PubMed Central PMCID: PMC6740712.","journal-title":"J Neurosci"},{"issue":"8","key":"818_CR76","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1007\/s12035-018-1450-9","volume":"56","author":"Z Li","year":"2019","unstructured":"Li Z, Jagadapillai R, Gozal E, Barnes G. Deletion of Semaphorin 3F in interneurons is associated with decreased GABAergic neurons, autism-like behavior, and increased oxidative stress cascades. Mol Neurobiol. 2019, Aug;56(8):5520\u201338. https:\/\/doi.org\/10.1007\/s12035-018-1450-9 PubMed PMID: 30635860; PubMed Central PMCID: PMC6614133.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"818_CR77","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/ejn.14081","volume":"48","author":"M Saint-Martin","year":"2018","unstructured":"Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J. Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci. 2018, Aug;48(3):1906\u201323. https:\/\/doi.org\/10.1111\/ejn.14081 PubMed PMID: 30028556.","journal-title":"Eur J Neurosci"},{"issue":"7","key":"818_CR78","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/mp.2014.103","volume":"20","author":"AG Chiocchetti","year":"2015","unstructured":"Chiocchetti AG, Kopp M, Waltes R, Haslinger D, Duketis E, Jarczok TA, et al. Variants of the CNTNAP2 5\u2032 promoter as risk factors for autism spectrum disorders: a genetic and functional approach. Mol. Psychiatry. 2015, Jul;20(7):839\u201349. https:\/\/doi.org\/10.1038\/mp.2014.103 PubMed PMID: 25224256.","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"818_CR79","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.molmed.2012.01.003","volume":"18","author":"O Pe\u00f1agarikano","year":"2012","unstructured":"Pe\u00f1agarikano O, Geschwind DH. What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med. 2012, Mar;18(3):156\u201363. https:\/\/doi.org\/10.1016\/j.molmed.2012.01.003 PubMed PMID: 22365836; PubMed Central PMCID: PMC3633421.","journal-title":"Trends Mol Med"},{"issue":"4","key":"818_CR80","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","volume":"97","author":"JM Dawes","year":"2018","unstructured":"Dawes JM, Weir GA, Middleton SJ, Patel R, Chisholm KI, Pettingill P, et al. Immune or genetic-mediated disruption of CASPR2 causes Pain hypersensitivity due to enhanced primary afferent excitability. Neuron. 2018, Feb, 21;97(4):806\u201322.e10. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.033 PubMed PMID: 29429934; PubMed Central PMCID: PMC6011627.","journal-title":"Neuron"},{"issue":"1","key":"818_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","volume":"147","author":"O Pe\u00f1agarikano","year":"2011","unstructured":"Pe\u00f1agarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell. 2011, Sep, 30;147(1):235\u201346. https:\/\/doi.org\/10.1016\/j.cell.2011.08.040 PubMed PMID: 21962519; PubMed Central PMCID: PMC3390029.","journal-title":"Cell"},{"issue":"10","key":"818_CR82","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.3390\/jcm11102725","volume":"11","author":"I Memis","year":"2022","unstructured":"Memis I, Mittal R, Furar E, White I, Eshraghi RS, Mittal J, et al. Altered blood brain barrier permeability and oxidative stress in Cntnap2 knockout Rat model. JCM. 2022, May, 11;11(10):2725. https:\/\/doi.org\/10.3390\/jcm11102725 PubMed PMID: 35628852; PubMed Central PMCID: PMC9146766.","journal-title":"JCM"},{"issue":"4","key":"818_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00439-020-02115-9","volume":"139","author":"Y An","year":"2020","unstructured":"An Y, Zhang L, Liu W, Jiang Y, Chen X, Lan X, et al. De Novo variants in the helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth. Hum Genet. 2020, Apr;139(4):499\u2013512. https:\/\/doi.org\/10.1007\/s00439-020-02115-9 PubMed PMID: 31980904.","journal-title":"Hum Genet"},{"issue":"1","key":"818_CR84","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41398-022-02189-1","volume":"12","author":"AJM Dingemans","year":"2022","unstructured":"Dingemans AJM, Truijen KMG, van de Ven S, Bernier R, Bongers EMHF, Bouman A, et al. The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8. Transl Psychiatry. 2022, Oct, 1;12(1):421. https:\/\/doi.org\/10.1038\/s41398-022-02189-1 PubMed PMID: 36182950; PubMed Central PMCID: PMC9526704.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"818_CR85","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2014.06.017","volume":"158","author":"R Bernier","year":"2014","unstructured":"Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell. 2014, Jul, 17;158(2):263\u201376. https:\/\/doi.org\/10.1016\/j.cell.2014.06.017 PubMed PMID: 24998929; PubMed Central PMCID: PMC4136921.","journal-title":"Cell"},{"issue":"1","key":"818_CR86","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41398-023-02611-2","volume":"13","author":"I Chatterjee","year":"2023","unstructured":"Chatterjee I, Getselter D, Ghanayem N, Harari R, Davis L, Bel S, et al. CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis. Transl Psychiatry. 2023, Oct, 2;13(1):305. https:\/\/doi.org\/10.1038\/s41398-023-02611-2 PubMed PMID: 37783686; PubMed Central PMCID: PMC10545671.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"818_CR87","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/s41467-025-57342-3","volume":"16","author":"KE McCluskey","year":"2025","unstructured":"McCluskey KE, Stovell KM, Law K, Kostyanovskaya E, Schmidt JD, Exner CRT, et al. Autism gene variants disrupt enteric neuron migration and cause gastrointestinal dysmotility. Nat Commun. 2025, Mar, 6;16(1):2238. https:\/\/doi.org\/10.1038\/s41467-025-57342-3 PubMed PMID: 40050271; PubMed Central PMCID: PMC11885846.","journal-title":"Nat Commun"},{"issue":"1","key":"818_CR88","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41467-022-28746-2","volume":"13","author":"Y Yu","year":"2022","unstructured":"Yu Y, Zhang B, Ji P, Zuo Z, Huang Y, Wang N, et al. Changes to gut amino acid transporters and microbiome associated with increased E\/I ratio in Chd8+\/\u2212 mouse model of ASD-like behavior. Nat Commun. 2022, Mar, 3;13(1):1151. https:\/\/doi.org\/10.1038\/s41467-022-28746-2 PubMed PMID: 35241668; PubMed Central PMCID: PMC8894489.","journal-title":"Nat Commun"},{"key":"818_CR89","doi-asserted-by":"publisher","unstructured":"Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr. 2009, Sep;90(3):867S\u201374S. https:\/\/doi.org\/10.3945\/ajcn.2009.27462BB PubMed PMID: 19571220; PubMed Central PMCID: PMC3136011.","DOI":"10.3945\/ajcn.2009.27462BB"},{"issue":"4","key":"818_CR90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0301-0082(90)90013-7","volume":"35","author":"M Ereci\u0144ska","year":"1990","unstructured":"Ereci\u0144ska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35(4):245\u201396. https:\/\/doi.org\/10.1016\/0301-0082(90)90013-7 PubMed PMID: 1980745.","journal-title":"Prog Neurobiol"},{"issue":"8","key":"818_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrmicro1952","volume":"6","author":"KS Kim","year":"2008","unstructured":"Kim KS. Mechanisms of microbial traversal of the blood\u2013brain barrier. Nat Rev Microbiol. 2008, Aug;6(8):625\u201334. https:\/\/doi.org\/10.1038\/nrmicro1952 PubMed PMID: 18604221; PubMed Central PMCID: PMC5206914.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"818_CR92","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41576-020-0231-2","volume":"21","author":"CP Schaaf","year":"2020","unstructured":"Schaaf CP, Betancur C, Yuen RKC, Parr JR, Skuse DH, Gallagher L, et al. A framework for an evidence-based gene list relevant to autism spectrum disorder. Nat Rev Genet. 2020, Jun;21(6):367\u201376. https:\/\/doi.org\/10.1038\/s41576-020-0231-2 PubMed PMID: 32317787; PubMed Central PMCID: PMC10357004.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"818_CR93","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/mp.2014.125","volume":"20","author":"TW Frazier","year":"2015","unstructured":"Frazier TW, Embacher R, Tilot AK, Koenig K, Mester J, Eng C. Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol. Psychiatry. 2015, Sep;20(9):1132\u201338. https:\/\/doi.org\/10.1038\/mp.2014.125 PubMed PMID: 25288137; PubMed Central PMCID: PMC4388743.","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"818_CR94","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/ejhg.2011.20","volume":"19","author":"JL Mester","year":"2011","unstructured":"Mester JL, Tilot AK, Rybicki LA, Frazier TW, Eng C. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet EJHG. 2011, Jul;19(7):763\u201368. https:\/\/doi.org\/10.1038\/ejhg.2011.20 PubMed PMID: 21343951; PubMed Central PMCID: PMC3137495.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"1","key":"818_CR95","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41398-021-01472-x","volume":"11","author":"R Jaini","year":"2021","unstructured":"Jaini R, Wolf MR, Yu Q, King AT, Frazier TW, Eng C. Maternal genetics influences fetal neurodevelopment and postnatal autism spectrum disorder-like phenotype by modulating in-utero immunosuppression. Transl Psychiatry. 2021, Jun, 5;11(1):348. https:\/\/doi.org\/10.1038\/s41398-021-01472-x PubMed PMID: 34091589; PubMed Central PMCID: PMC8179926.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"818_CR96","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10803-010-1006-y","volume":"40","author":"H\u00d3 Atlad\u00f3ttir","year":"2010","unstructured":"Atlad\u00f3ttir H\u00d3, Thorsen P, \u00d8stergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010, Dec;40(12):1423\u201330. https:\/\/doi.org\/10.1007\/s10803-010-1006-y PubMed PMID: 20414802.","journal-title":"J Autism Dev Disord"},{"issue":"12","key":"818_CR97","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.biopsych.2024.11.009","volume":"97","author":"RM Gardner","year":"2025","unstructured":"Gardner RM, Brynge M, Sj\u00f6qvist H, Dalman C, Karlsson H. Maternal immune activation and autism in offspring: what is the evidence for causation? Biol Psychiatry. 2025, Jun, 15;97(12):1127\u201338. https:\/\/doi.org\/10.1016\/j.biopsych.2024.11.009 PubMed PMID: 39581290.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"818_CR98","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41582-021-00530-8","volume":"17","author":"VX Han","year":"2021","unstructured":"Han VX, Patel S, Jones HF, Dale RC. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol. 2021, Sep;17(9):564\u201379. https:\/\/doi.org\/10.1038\/s41582-021-00530-8.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"818_CR99","doi-asserted-by":"publisher","first-page":"111548","DOI":"10.1016\/j.isci.2024.111548","volume":"28","author":"E O\u2019Neill","year":"2025","unstructured":"O\u2019Neill E, Curham L, N\u00ed Chasaide C, O\u2019Brien S, McManus G, Moran B, et al. Neonatal infection with Bordetella pertussis promotes autism-like phenotypes in mice. iScience. 2025, Jan, 17;28(1):111548. https:\/\/doi.org\/10.1016\/j.isci.2024.111548 PubMed PMID: 39897939; PubMed Central PMCID: PMC11784780.","journal-title":"iScience"},{"issue":"21","key":"818_CR100","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1073\/pnas.1922287117","volume":"117","author":"Y Pu","year":"2020","unstructured":"Pu Y, Yang J, Chang L, Qu Y, Wang S, Zhang K, et al. Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase. Proc Natl Acad Sci USA. 2020, May, 26;117(21):11753\u201359. https:\/\/doi.org\/10.1073\/pnas.1922287117 PubMed PMID: 32398374; PubMed Central PMCID: PMC7260984.","journal-title":"Proc Natl Acad Sci USA"},{"key":"818_CR101","doi-asserted-by":"publisher","unstructured":"von Ehrenstein Os, Ling C, Cui X, Cockburn M, Park AS, Yu F, et al. Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case-control study. BMJ. 2019, Mar, 20;364:l962. https:\/\/doi.org\/10.1136\/bmj.l962 PubMed PMID: 30894343; PubMed Central PMCID: PMC6425996.","DOI":"10.1136\/bmj.l962"},{"issue":"285","key":"818_CR102","doi-asserted-by":"publisher","first-page":"117060","DOI":"10.1016\/j.ecoenv.2024.117060","volume":"285","author":"X He","year":"2024","unstructured":"He X, Yang Y, Zhou S, Wei Q, Zhou H, Tao J, et al. Alterations in microbiota-metabolism-circRNA crosstalk in autism spectrum disorder-like behaviours caused by maternal exposure to glyphosate-based herbicides in mice. Ecotox Environ Safe. 2024, Oct;285(285):117060. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117060 PubMed PMID: 39299209.","journal-title":"Ecotox Environ Safe"},{"issue":"1","key":"818_CR103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000509109","volume":"42","author":"D Chaliha","year":"2020","unstructured":"Chaliha D, Albrecht M, Vaccarezza M, Takechi R, Lam V, Al-Salami H, et al. A systematic review of the valproic-acid-induced rodent model of autism. Dev Neurosci. 2020;42(1):12\u201348. https:\/\/doi.org\/10.1159\/000509109 PubMed PMID: 32810856.","journal-title":"Dev Neurosci"},{"issue":"5\u20136","key":"818_CR104","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000492113","volume":"25","author":"I Deckmann","year":"2018","unstructured":"Deckmann I, Schwingel GB, Fontes-Dutra M, Bambini-Junior V, Gottfried C. Neuroimmune alterations in autism: a translational analysis focusing on the animal model of autism induced by Prenatal exposure to valproic acid. Neuroimmunomodulation. 2018;25(5\u20136):285\u201399. https:\/\/doi.org\/10.1159\/000492113 PubMed PMID: 30157484.","journal-title":"Neuroimmunomodulation"},{"issue":"Pt A","key":"818_CR105","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018, Jan;299(Pt A):217\u201327. https:\/\/doi.org\/10.1016\/j.expneurol.2017.04.017 PubMed PMID: 28472621.","journal-title":"Exp Neurol"},{"issue":"7","key":"818_CR106","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jdn.10137","volume":"81","author":"I Deckmann","year":"2021","unstructured":"Deckmann I, Santos-Terra J, Fontes-Dutra M, K\u00f6rbes-Rockenbach M, Bauer-Negrini G, Schwingel GB, et al. Resveratrol prevents brain edema, blood\u2013brain barrier permeability, and altered aquaporin profile in autism animal model. Intl J Devlp Neurosci. 2021, Nov;81(7):579\u2013604. https:\/\/doi.org\/10.1002\/jdn.10137 PubMed PMID: 34196408.","journal-title":"Intl J Devlp Neurosci"},{"issue":"2","key":"818_CR107","doi-asserted-by":"publisher","first-page":"247","DOI":"10.32598\/bcn.2021.2966.1","volume":"14","author":"H Kumar","year":"2023","unstructured":"Kumar H, Kulkarni GT, Diwan V, Sharma B. Shielding effect of ryanodine receptor modulator in Rat model of autism. BCN. 2023;14(2):247\u201362. https:\/\/doi.org\/10.32598\/bcn.2021.2966.1 PubMed PMID: 38107532; PubMed Central PMCID: PMC10719969.","journal-title":"BCN"},{"issue":"4","key":"818_CR108","doi-asserted-by":"publisher","first-page":"725","DOI":"10.9758\/cpn.2022.20.4.725","volume":"20","author":"H Kumar","year":"2022","unstructured":"Kumar H, Diwan V, Sharma B. Protective effect of Nimodipine against valproic-acid induced biochemical and behavioral phenotypes of autism. Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol. 2022, Nov, 30;20(4):725\u201336. https:\/\/doi.org\/10.9758\/cpn.2022.20.4.725 PubMed PMID: 36263647; PubMed Central PMCID: PMC9606438.","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"818_CR109","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2015.10.007","volume":"91","author":"H Kumar","year":"2015","unstructured":"Kumar H, Sharma BM, Sharma B. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Neurochemistry Int. 2015, Dec;91:34\u201345. https:\/\/doi.org\/10.1016\/j.neuint.2015.10.007 PubMed PMID: 26498253.","journal-title":"Neurochemistry Int"},{"key":"818_CR110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","volume":"124","author":"H Kumar","year":"2016","unstructured":"Kumar H, Sharma B. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats. Brain Res Bull. 2016, Jun;124:27\u201339. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.013 PubMed PMID: 27034117.","journal-title":"Brain Res Bull"},{"key":"818_CR111","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","volume":"1630","author":"H Kumar","year":"2016","unstructured":"Kumar H, Sharma B. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats. Brain Res. 2016, Jan, 1;1630:83\u201397. https:\/\/doi.org\/10.1016\/j.brainres.2015.10.052 PubMed PMID: 26551768.","journal-title":"Brain Res"},{"issue":"7","key":"818_CR112","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1007\/s12035-023-03826-6","volume":"61","author":"S Mehra","year":"2024","unstructured":"Mehra S, Ahsan AU, Sharma M, Budhwar M, Chopra M. Gestational Fisetin Exerts Neuroprotection by Regulating Mitochondria-Directed Canonical Wnt signaling, BBB integrity, and Apoptosis in Prenatal VPA-Induced rodent model of autism. BBB Integrity, Apoptosis Prenatal VPA-Induced Rodent Model Autism. Mol Neurobiol. 2024, Jul;61(7):4001\u201320. https:\/\/doi.org\/10.1007\/s12035-023-03826-6.","journal-title":"BBB Integrity, Apoptosis Prenatal VPA-Induced Rodent Model Autism. Mol Neurobiol"},{"key":"818_CR113","doi-asserted-by":"publisher","first-page":"105516","DOI":"10.1016\/j.jff.2023.105516","volume":"104","author":"NB Tran","year":"2023","unstructured":"Tran NB, Lee H, Lee SJ. Extracts from the edible insects gryllus bimaculatus and oxya chinensis sinuosa as an effective postnatal therapy for improving autistic behavior through blood-brain barrier control and gut microbiota. J Funct Foods. 2023, May;104:105516. https:\/\/doi.org\/10.1016\/j.jff.2023.105516.","journal-title":"J Funct Foods"},{"issue":"1","key":"818_CR114","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-019-05357-2","volume":"237","author":"S Mohammadi","year":"2020","unstructured":"Mohammadi S, Asadi-Shekaari M, Basiri M, Parvan M, Shabani M, Nozari M. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function. Psychopharmacol (Berl). 2020, Jan;237(1):199\u2013208. https:\/\/doi.org\/10.1007\/s00213-019-05357-2 PubMed PMID: 31595334.","journal-title":"Psychopharmacol (Berl)"},{"issue":"2","key":"818_CR115","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4062\/biomolther.2018.230","volume":"27","author":"S Kim","year":"2019","unstructured":"Kim S, Kim DG, Gonzales EL, Mabunga DFN, Shin D, Jeon SJ, et al. Effects of intraperitoneal N-methyl-D-aspartate (NMDA) administration on Nociceptive\/Repetitive behaviors in juvenile mice. Biomol Ther. 2019, Mar, 1;27(2):168\u201377. https:\/\/doi.org\/10.4062\/biomolther.2018.230 PubMed PMID: 30580503; PubMed Central PMCID: PMC6430226.","journal-title":"Biomol Ther"},{"issue":"1","key":"818_CR116","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13041-020-00626-0","volume":"13","author":"H Choi","year":"2020","unstructured":"Choi H, Kim IS, Mun JY. Propionic acid induces dendritic spine loss by MAPK\/ERK signaling and dysregulation of autophagic flux. Mol Brain. 2020, Jun, 2;13(1):86. https:\/\/doi.org\/10.1186\/s13041-020-00626-0 PubMed PMID: 32487196; PubMed Central PMCID: PMC7268420.","journal-title":"Mol Brain"},{"issue":"1","key":"818_CR117","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1742-2094-9-74","volume":"9","author":"AK El-Ansary","year":"2012","unstructured":"El-Ansary AK, Ben Bacha A, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation. 2012, Apr;9(1):74. https:\/\/doi.org\/10.1186\/1742-2094-9-74 PubMed PMID: 22531301; PubMed Central PMCID: PMC3425128.","journal-title":"J Neuroinflammation"},{"key":"818_CR118","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jff.2018.05.065","volume":"47","author":"R Bhandari","year":"2018","unstructured":"Bhandari R, Paliwal JK, Kuhad A. Naringenin and its nanocarriers as potential phytotherapy for autism spectrum disorders. J Funct Foods. 2018, Aug;47:361\u201375. https:\/\/doi.org\/10.1016\/j.jff.2018.05.065.","journal-title":"J Funct Foods"},{"issue":"1","key":"818_CR119","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biopsych.2018.07.004","volume":"85","author":"A Forsingdal","year":"2019","unstructured":"Forsingdal A, J\u00f8rgensen TN, Olsen L, Werge T, Didriksen M, Nielsen J. Can animal models of Copy number variants that predispose to schizophrenia elucidate underlying biology? Biol Psychiatry. 2019, Jan, 1;85(1):13\u201324. https:\/\/doi.org\/10.1016\/j.biopsych.2018.07.004 PubMed PMID: 30144930.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"818_CR120","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","volume":"1","author":"DM McDonald-McGinn","year":"2015","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JAS, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015, Nov;1(1):15071. https:\/\/doi.org\/10.1038\/nrdp.2015.71 PubMed PMID: 27189754; PubMed Central PMCID: PMC4900471.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"818_CR121","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/brain\/awab055","volume":"144","author":"AM Crockett","year":"2021","unstructured":"Crockett AM, Ryan SK, V\u00e1squez AH, Canning C, Kanyuch N, Kebir H, et al. Disruption of the blood\u2013brain barrier in 22q11.2 deletion syndrome. Brain J Neurol. 2021, Jun, 22;144(5):1351\u201360. https:\/\/doi.org\/10.1093\/brain\/awab055 PubMed PMID: 33876226; PubMed Central PMCID: PMC8219368.","journal-title":"Brain J Neurol"},{"key":"818_CR122","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neubiorev.2018.07.001","volume":"117","author":"N Cattane","year":"2020","unstructured":"Cattane N, Richetto J, Cattaneo A. Prenatal exposure to environmental insults and enhanced risk of developing schizophrenia and autism spectrum disorder: focus on biological pathways and epigenetic mechanisms. Neurosci. Biobehav. Rev. 2020, Oct;117:253\u201378. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.07.001.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR123","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neubiorev.2019.06.020","volume":"104","author":"E Guma","year":"2019","unstructured":"Guma E, Plitman E, Chakravarty MM. The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: a translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia. Neurosci. Biobehav. Rev. 2019, Sep;104:141\u201357. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.06.020.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR124","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/7854_2022_398","volume":"61","author":"U Meyer","year":"2023","unstructured":"Meyer U. Sources and translational relevance of heterogeneity in maternal immune activation models. Curr Top Behav Neurosci. 2023;61:71\u201391. https:\/\/doi.org\/10.1007\/7854_2022_398 PubMed PMID: 36306055.","journal-title":"Curr Top Behav Neurosci"},{"issue":"11","key":"818_CR125","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.tins.2019.08.001","volume":"42","author":"U Meyer","year":"2019","unstructured":"Meyer U. Neurodevelopmental resilience and susceptibility to maternal immune activation. Trends Neurosciences. 2019, Nov;42(11):793\u2013806. https:\/\/doi.org\/10.1016\/j.tins.2019.08.001 PubMed PMID: 31493924.","journal-title":"Trends Neurosciences"},{"key":"818_CR126","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpsychires.2018.02.007","volume":"100","author":"LR Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es LR, Sangiogo G, Tashiro MH, Generoso JS, Faller CJ, Dominguini D, et al. Maternal immune activation induced by lipopolysaccharide triggers immune response in pregnant mother and fetus, and induces behavioral impairment in adult rats. J Psychiatric Res. 2018, May;100:71\u201383. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.007.","journal-title":"J Psychiatric Res"},{"key":"818_CR127","doi-asserted-by":"publisher","unstructured":"Rasile M, Lauranzano E, Faggiani E, Ravanelli MM, Colombo FS, Mirabella F, et al. Maternal immune activation leads to defective brain\u2013blood vessels and intracerebral hemorrhages in male offspring. Embo J. 2022, Dec, 1;41(23):e111192. https:\/\/doi.org\/10.15252\/embj.2022111192 PubMed PMID: 36314682; PubMed Central PMCID: PMC9713716.","DOI":"10.15252\/embj.2022111192"},{"issue":"5","key":"818_CR128","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/schbul\/sbad098","volume":"49","author":"SB Powell","year":"2023","unstructured":"Powell SB, Swerdlow NR. The relevance of animal models of social isolation and social motivation for understanding schizophrenia: review and future directions. Schizophr Bull. 2023, Sep, 7;49(5):1112\u201326. https:\/\/doi.org\/10.1093\/schbul\/sbad098 PubMed PMID: 37527471; PubMed Central PMCID: PMC10483472.","journal-title":"Schizophr Bull"},{"issue":"3","key":"818_CR129","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s12035-016-9791-8","volume":"54","author":"S Schiavone","year":"2017","unstructured":"Schiavone S, Mhillaj E, Neri M, Morgese MG, Tucci P, Bove M, et al. Early loss of blood-brain barrier integrity precedes NOX2 elevation in the prefrontal cortex of an animal model of psychosis. Mol Neurobiol. 2017, Apr;54(3):2031\u201344. https:\/\/doi.org\/10.1007\/s12035-016-9791-8 PubMed PMID: 26910819; PubMed Central PMCID: PMC5355521.","journal-title":"Mol Neurobiol"},{"issue":"24","key":"818_CR130","doi-asserted-by":"publisher","first-page":"17432","DOI":"10.3390\/ijms242417432","volume":"24","author":"PP Lagod","year":"2023","unstructured":"Lagod PP, Naser SA. The role of short-chain fatty acids and altered microbiota composition in autism spectrum disorder: a comprehensive literature review. IJMS. 2023, Dec, 13;24(24):17432. https:\/\/doi.org\/10.3390\/ijms242417432 PubMed PMID: 38139261; PubMed Central PMCID: PMC10743890.","journal-title":"IJMS"},{"issue":"4","key":"818_CR131","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.anaerobe.2010.06.008","volume":"16","author":"SM Finegold","year":"2010","unstructured":"Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010, Aug;16(4):444\u201353. https:\/\/doi.org\/10.1016\/j.anaerobe.2010.06.008 PubMed PMID: 20603222.","journal-title":"Anaerobe"},{"issue":"12","key":"818_CR132","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/mp.2017.161","volume":"22","author":"RE Gur","year":"2017","unstructured":"Gur RE, Bassett AS, McDonald-McGinn DM, Bearden CE, Chow E, Emanuel BS, et al. A neurogenetic model for the study of schizophrenia spectrum disorders: the international 22q11.2 deletion syndrome brain behavior consortium. Mol. Psychiatry. 2017, Dec;22(12):1664\u201372. https:\/\/doi.org\/10.1038\/mp.2017.161 PubMed PMID: 28761081; PubMed Central PMCID: PMC5935262.","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"818_CR133","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019, Oct, 1;99(4):1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018 PubMed PMID: 31460832.","journal-title":"Physiol Rev"},{"key":"818_CR134","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.anaerobe.2017.12.007","volume":"49","author":"DW Kang","year":"2018","unstructured":"Kang DW, Ilhan ZE, Isern NG, Hoyt DW, Howsmon DP, Shaffer M, et al. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. Anaerobe. 2018, Feb;49:121\u201331. https:\/\/doi.org\/10.1016\/j.anaerobe.2017.12.007 PubMed PMID: 29274915.","journal-title":"Anaerobe"},{"issue":"3","key":"818_CR135","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/bmm.14.12","volume":"8","author":"L Wang","year":"2014","unstructured":"Wang L, Conlon MA, Christophersen CT, Sorich MJ, Angley MT. Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders. Biomarker Med. 2014;8(3):331\u201344. https:\/\/doi.org\/10.2217\/bmm.14.12 PubMed PMID: 24712423.","journal-title":"Biomarker Med"},{"issue":"7","key":"818_CR136","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013, Dec, 19;155(7):1451\u201363. https:\/\/doi.org\/10.1016\/j.cell.2013.11.024 PubMed PMID: 24315484; PubMed Central PMCID: PMC3897394.","journal-title":"Cell"},{"issue":"10","key":"818_CR137","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1124\/dmd.115.063826","volume":"43","author":"CS Rosenfeld","year":"2015","unstructured":"Rosenfeld CS. Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos. 2015, Oct;43(10):1557\u201371. https:\/\/doi.org\/10.1124\/dmd.115.063826 PubMed PMID: 25852213.","journal-title":"Drug Metab Dispos"},{"key":"818_CR138","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbi.2018.05.015","volume":"73","author":"L Tabouy","year":"2018","unstructured":"Tabouy L, Getselter D, Ziv O, Karpuj M, Tabouy T, Lukic I, et al. Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain Behav Immun. 2018, Oct;73:310\u201319. https:\/\/doi.org\/10.1016\/j.bbi.2018.05.015 PubMed PMID: 29787855.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"818_CR139","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","volume":"5","author":"DW Kang","year":"2017","unstructured":"Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017, Jan, 23;5(1):10. https:\/\/doi.org\/10.1186\/s40168-016-0225-7 PubMed PMID: 28122648; PubMed Central PMCID: PMC5264285.","journal-title":"Microbiome"},{"key":"818_CR140","doi-asserted-by":"publisher","unstructured":"Castro-Nallar E, Bendall ML, P\u00e9rez-Losada M, Sabuncyan S, Severance EG, Dickerson FB, et al. Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls. PeerJ. 2015;3:e1140. https:\/\/doi.org\/10.7717\/peerj.1140 PubMed PMID: 26336637; PubMed Central PMCID: PMC4556144.","DOI":"10.7717\/peerj.1140"},{"issue":"5","key":"818_CR141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11920-015-0574-0","volume":"17","author":"EG Severance","year":"2015","unstructured":"Severance EG, Prandovszky E, Castiglione J, Yolken RH. Gastroenterology issues in schizophrenia: why the gut matters. Curr Psychiatry Rep. 2015, May;17(5):27. https:\/\/doi.org\/10.1007\/s11920-015-0574-0 PubMed PMID: 25773227; PubMed Central PMCID: PMC4437570.","journal-title":"Curr Psychiatry Rep"},{"key":"818_CR142","doi-asserted-by":"publisher","unstructured":"Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 2019, Feb;5(2):eaau8317. https:\/\/doi.org\/10.1126\/sciadv.aau8317 PubMed PMID: 30775438; PubMed Central PMCID: PMC6365110.","DOI":"10.1126\/sciadv.aau8317"},{"issue":"3","key":"818_CR143","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","volume":"22","author":"CM Sellgren","year":"2019","unstructured":"Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, et al. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat. Neurosci. 2019, Mar;22(3):374\u201385. https:\/\/doi.org\/10.1038\/s41593-018-0334-7 PubMed PMID: 30718903; PubMed Central PMCID: PMC6410571.","journal-title":"Nat. Neurosci"},{"key":"818_CR144","doi-asserted-by":"publisher","unstructured":"Dickerson FB, Stallings C, Origoni A, Katsafanas E, Savage CLG, Schweinfurth LAB, et al. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord. 2014;16(1):PCC.13m01579. https:\/\/doi.org\/10.4088\/PCC.13m01579 PubMed PMID: 24940526; PubMed Central PMCID: PMC4048142.","DOI":"10.4088\/PCC.13m01579"},{"key":"818_CR145","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2016.11.019","volume":"62","author":"EG Severance","year":"2017","unstructured":"Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, et al. Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study. Brain Behav Immun. 2017, May;62:41\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2016.11.019 PubMed PMID: 27871802; PubMed Central PMCID: PMC5373951.","journal-title":"Brain Behav Immun"},{"key":"818_CR146","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neubiorev.2021.07.001","volume":"128","author":"C Davies","year":"2021","unstructured":"Davies C, Mishra D, Eshraghi RS, Mittal J, Sinha R, Bulut E, et al. Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: a systematic review. Neurosci. Biobehav. Rev. 2021, Sep;128:549\u201357. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.07.001 PubMed PMID: 34271306.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR147","doi-asserted-by":"publisher","first-page":"1288256","DOI":"10.3389\/fimmu.2023.1288256","volume":"14","author":"Y Gan","year":"2024","unstructured":"Gan Y, Chen Y, Zhong H, Liu Z, Geng J, Wang H, et al. Gut microbes in central nervous system development and related disorders. Front. Immunol. 2024;14:1288256. https:\/\/doi.org\/10.3389\/fimmu.2023.1288256 PubMed PMID: 38343438; PubMed Central PMCID: PMC10854220.","journal-title":"Front. Immunol"},{"key":"818_CR148","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/7854_2018_84","volume":"44","author":"EG Severance","year":"2020","unstructured":"Severance EG, Yolken RH. From infection to the microbiome: an evolving role of microbes in schizophrenia. Curr Top Behav Neurosci. 2020;44:67\u201384. https:\/\/doi.org\/10.1007\/7854_2018_84 PubMed PMID: 30847804; PubMed Central PMCID: PMC6732248.","journal-title":"Curr Top Behav Neurosci"},{"issue":"2","key":"818_CR149","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/biom12020181","volume":"12","author":"SI Deutsch","year":"2022","unstructured":"Deutsch SI, Luyo ZNM, Burket JA. Targeted NMDA receptor interventions for autism: developmentally determined expression of GluN2B and GluN2A-Containing receptors and balanced allosteric modulatory approaches. Biomolecules. 2022, Jan, 22;12(2):181. https:\/\/doi.org\/10.3390\/biom12020181 PubMed PMID: 35204682; PubMed Central PMCID: PMC8961601.","journal-title":"Biomolecules"},{"key":"818_CR150","doi-asserted-by":"publisher","first-page":"106019","DOI":"10.1016\/j.neubiorev.2025.106019","volume":"169","author":"S Aboul-Fotouh","year":"2025","unstructured":"Aboul-Fotouh S, Zohny SM, Elnahas EM, Habib MZ, Hassan GA. Can memantine treat autism? Answers from preclinical and clinical studies. Neurosci. Biobehav. Rev. 2025, Feb;169:106019. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106019 PubMed PMID: 39826825.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR151","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neubiorev.2016.05.013","volume":"70","author":"A Caballero","year":"2016","unstructured":"Caballero A, Granberg R, Tseng KY. Mechanisms contributing to prefrontal cortex maturation during adolescence. Neurosci. Biobehav. Rev. 2016, Nov;70:4\u201312. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.05.013.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"7","key":"818_CR152","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tins.2016.04.010","volume":"39","author":"A Caballero","year":"2016","unstructured":"Caballero A, Tseng KY. Gabaergic function as a limiting factor for prefrontal maturation during Adolescence. Trends Neurosciences. 2016, Jul;39(7):441\u201348. https:\/\/doi.org\/10.1016\/j.tins.2016.04.010.","journal-title":"Trends Neurosciences"},{"key":"818_CR153","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neubiorev.2018.09.005","volume":"94","author":"B Larsen","year":"2018","unstructured":"Larsen B, Luna B. Adolescence as a neurobiological critical period for the development of higher-order cognition. Neurosci. Biobehav. Rev. 2018, Nov;94:179\u201395. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.09.005.","journal-title":"Neurosci. Biobehav. Rev"},{"key":"818_CR154","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2017.04.016","volume":"194","author":"JY Khokhar","year":"2018","unstructured":"Khokhar JY, Dwiel LL, Henricks AM, Doucette WT, Green AI. The link between schizophrenia and substance use disorder: a unifying hypothesis. Schizophr Res. 2018, Apr;194:78\u201385. https:\/\/doi.org\/10.1016\/j.schres.2017.04.016.","journal-title":"Schizophr Res"},{"key":"818_CR155","doi-asserted-by":"publisher","unstructured":"Mart\u00edn-Cuevas C, Ramos-Herrero VD, Flores-Mart\u00ednez \u00c1, Gonz\u00e1lez-Recio I, Mart\u00ednez-Chantar ML, Leza JC, et al. Disruption of reelin signaling in a dual-hit mouse model of schizophrenia: impact of postnatal \u03b49-tetrahydrocannabinol exposure in a maternal immune activation model [Internet]. Neuroscience. 2025. https:\/\/doi.org\/10.1101\/2025.07.25.666721 http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.07.25.666721. [2025 Sep 18].","DOI":"10.1101\/2025.07.25.666721"},{"issue":"4","key":"818_CR156","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41380-023-02382-8","volume":"29","author":"N Okada","year":"2024","unstructured":"Okada N, Yahata N, Koshiyama D, Morita K, Sawada K, Kanata S, et al. Longitudinal trajectories of anterior cingulate glutamate and subclinical psychotic experiences in early adolescence: the impact of bullying victimization. Mol. Psychiatry. 2024, Apr;29(4):939\u201350. https:\/\/doi.org\/10.1038\/s41380-023-02382-8.","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"818_CR157","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018, Mar;14(3):133\u201350. https:\/\/doi.org\/10.1038\/nrneurol.2017.188 PubMed PMID: 29377008; PubMed Central PMCID: PMC5829048.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"818_CR158","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019, Feb;25(2):270\u201376. https:\/\/doi.org\/10.1038\/s41591-018-0297-y PubMed PMID: 30643288; PubMed Central PMCID: PMC6367058.","journal-title":"Nat Med"},{"key":"818_CR159","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnagi.2014.00171","volume":"6","author":"S Takeda","year":"2014","unstructured":"Takeda S, Sato N, Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive\/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci. 2014;6:171. https:\/\/doi.org\/10.3389\/fnagi.2014.00171 PubMed PMID: 25120476; PubMed Central PMCID: PMC4114193.","journal-title":"Front Aging Neurosci"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00818-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00818-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00818-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:50:36Z","timestamp":1782474636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00818-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00818-1","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}